Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study-Reference-Cited by-同舟云学术

Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study

Published:2020-01-01 Issue:1 Volume:9 Page:2368-2378
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Yang Chao¹^ORCID,Jiang Min¹,Wang Xiaohui¹^ORCID,Tang Xiujuan¹,Fang Shisong¹,Li Hao¹,Zuo Le¹,Jiang Yixiang¹,Zhong Yifan¹,Chen Qiongcheng¹,Zheng Chenli¹,Wang Lei¹,Wu Shuang¹,Wu Weihua¹,Liu Hui¹,Yuan Jing²,Liao Xuejiao²,Zhang Zhen¹,Shi Xiaolu¹,Geng Yijie¹,Zhang Huan³,Zheng Huanying³,Wan Min⁴,Lu Linying¹,Ren Xiaohu¹,Cui Yujun⁵,Zou Xuan¹,Feng Tiejian¹,Xia Junjie¹,Yang Ruifu⁵,Liu Yingxia²,Mei Shujiang¹^ORCID,Li Baisheng³,Yang Zhengrong¹,Hu Qinghua¹

Affiliation:

1. Shenzhen Center for Disease Control and Prevention, Shenzhen, People’s Republic of China

2. State Key Discipline of Infectious Disease, National Clinical Research Center for infectious disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, People’s Republic of China

3. Guangdong Provincial Center for Disease Control and Prevention, Guangdong, People’s Republic of China

4. Shenzhen LongHua District Maternity and Child Healthcare Hospital, Shenzhen, People’s Republic of China

5. State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People’s Republic of China

Funder

China National Science and Technology Major Projects Foundation

Sanming Project of Medicine in Shenzhen

Shenzhen Key Medical Discipline Construction Fund

Special Foundation of Science and Technology Innovation Strategy of Guangdong Province of China

China Postdoctoral Science Foundation

Shenzhen Committee of Scientific and Technical Innovation grant

Beijing Municipal Science and Technology Project

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1837018

Reference19 articles.

1. Clinical Characteristics of Coronavirus Disease 2019 in China

2. WHO. Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.

3. Positive RT-PCR Test Results in Patients Recovered From COVID-19

4. False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Differences in Lymphocyte Subsets and CD4+ T Cells Immune Activation Between Re-detectable Positive and Non-re-detectable Positive COVID-19 Convalescent Patients;Archives of Clinical Infectious Diseases;2024-01-29

2. Engineered Nanovesicles Expressing Bispecific Single Chain Variable Fragments to Protect against SARS-CoV-2 Infection;ACS Biomaterials Science & Engineering;2023-11-16

3. A Greater Increase in Complement C5a Receptor 1 Level at Onset and a Smaller Decrease in Immunoglobulin G Level after Recovery in Severer Coronavirus Disease 2019 Patients: A New Analysis of Existing Data with a New Two-Tailed t-Test;Biology;2023-08-28

4. Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study;The Lancet Infectious Diseases;2023-06

5. Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19;Epidemiology and Infection;2023